Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial
Sharana Mahomed, Nigel Garrett, Quarraisha A Karim, Nonhlanhla Y Zuma, Edmund Capparelli, Cheryl Baxter, Tanuja Gengiah, Derseree Archary, Natasha Samsunder, Nicole D Rose, Penny Moore, Carolyn Williamson, Dan H Barouch, Patricia E Fast, Bruno Pozzetto, Catherine Hankins, Kevin Carlton, Julie Ledgerwood, Lynn Morris, John Mascola, Salim Abdool Karim
BMJ Open Nov 2020, 10 (11) e042247; DOI: 10.1136/bmjopen-2020-042247
